Axsome Therapeutics, Inc. (AXSM)

Axsome Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	386.19	200.84	86.47	183.88	219.97
Cash & Cash Equivalents	386.19	200.84	86.47	183.88	219.97
Cash Growth	92.29%	132.26%	-52.97%	-16.41%	1474.70%
Receivables	94.82	37.7	0	0	0
Inventory	15.14	4.32	0	0	0
Other Current Assets	8.12	2.78	0.05	0.15	0.41
Total Current Assets	504.26	245.64	86.52	184.02	220.38
Property, Plant & Equipment	7.62	1.14	0.94	1.79	0.03
Goodwill and Intangibles	65.33	69.97	0	0	0
Other Long-Term Assets	11.03	14.72	0.32	0.32	0.14
Total Long-Term Assets	83.97	85.83	1.27	2.11	0.17
Total Assets	588.24	331.48	87.79	186.13	220.55
Accounts Payable	40.68	38.61	13.15	13.5	10.94
Current Debt	1.27	0.43	0.62	1.22	2.6
Other Current Liabilities	96.91	57.53	9.3	8.71	10.95
Total Current Liabilities	138.85	96.56	23.07	23.44	24.49
Long-Term Debt	185.11	94.26	49.09	48.9	17.33
Other Long-Term Liabilities	73.3	31.1	0	0	0
Total Long-Term Liabilities	258.41	125.36	49.09	48.9	17.33
Total Liabilities	397.26	221.92	72.15	72.34	41.83
Total Debt	186.37	94.68	49.71	50.12	19.93
Debt Growth	96.84%	90.47%	-0.83%	151.44%	188.46%
Retained Earnings	-835.57	-596.33	-409.2	-278.8	-175.9
Shareholders' Equity	190.98	109.56	15.63	113.79	178.72
Net Cash / Debt	199.82	106.16	36.76	133.75	200.03
Net Cash / Debt Growth	88.23%	188.77%	-72.51%	-33.13%	2734.14%
Net Cash Per Share	4.40	2.61	0.98	3.59	5.88
Working Capital	365.41	149.08	63.45	160.59	195.88
Book Value Per Share	4.20	2.69	0.41	3.06	5.25

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).